Orfadin® | |
Brand Name: | Orfadin® |
Active Ingredient: | nitisinone |
Strength(s): | 2 mg, 5 mg, and 10 mg |
Dosage Form(s): | Capsules |
Company Name: | Swedish Orphan International, AB |
Availability: | Prescription only |
*Date Approved by FDA: | January 18, 2002 |
*Approval by FDA does not mean that the drug is available for consumers at this time. |
What is Orfadin used for?
Orfadin is used to treat hereditary tyrosinemia type 1, a rare pediatric disease causing progressive liver failure and liver cancer in young children. It is used along with a diet restricting the amino acids tyrosine and phenylalanine. Special Warnings with Orfadin: Patients and their parents or caregivers should tell their doctor right away about:
What should I tell my health care provider?
What are some possible side effects of Orfadin? (This is NOT a complete list of side effects reported with Orfadin. Your health care provider can discuss with you a more complete list of side effects.) The most common side effects of Orfadin were related to high tyrosine levels due to patients not eating the right foods as well as rare cases of a decrease in platelet and white blood cell counts. For more detailed information about Orfadin, ask your health care provider or pharmacist. Posted: 11/22/02 |